Epidemiology of Parkinson's disease

Greenamyre, 2004, Biomedicine: Parkinson's—divergent causes, convergent mechanisms, Science, 304, 1120, 10.1126/science.1098966 Litvan, 2003, Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders, Mov Disord, 18, 467, 10.1002/mds.10459 de Rijk, 1997, A population perspective on diagnostic criteria for Parkinson's disease, Neurology, 48, 1277, 10.1212/WNL.48.5.1277 de Rijk, 1995, Prevalence of Parkinson's disease in the elderly: the Rotterdam Study, Neurology, 45, 2143, 10.1212/WNL.45.12.2143 Benito-Leon, 2003, Prevalence of PD and other types of parkinsonism in three elderly populations of central Spain, Mov Disord, 18, 267, 10.1002/mds.10362 Schoenberg, 1988, Comparison of the prevalence of Parkinson's disease in black populations in the rural United States and in rural Nigeria: door-to-door community studies, Neurology, 38, 645, 10.1212/WNL.38.4.645 Tison, 1994, Prevalence of Parkinson's disease in the elderly: a population study in Gironde, France, Acta Neurol Scand, 90, 111, 10.1111/j.1600-0404.1994.tb02689.x Morgante, 1992, Prevalence of Parkinson's disease and other types of parkinsonism: a door-to-door survey in three Sicilian municipalities, Neurology, 42, 1901, 10.1212/WNL.42.10.1901 de Rijk, 1997, Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease, J Neurol Neurosurg Psychiatry, 62, 10, 10.1136/jnnp.62.1.10 Claveria, 2002, Prevalence of Parkinson's disease in Cantalejo, Spain: a door-to-door survey, Mov Disord, 17, 242, 10.1002/mds.10087 Benito-Leon, 2004, Incidence of Parkinson disease and parkinsonism in three elderly populations of central Spain, Neurology, 62, 734, 10.1212/01.WNL.0000113727.73153.68 de Lau, 2004, Incidence of parkinsonism and Parkinson disease in a general population: the Rotterdam Study, Neurology, 63, 1240, 10.1212/01.WNL.0000140706.52798.BE Van Den Eeden, 2003, Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity, Am J Epidemiol, 157, 1015, 10.1093/aje/kwg068 Nussbaum, 2003, Alzheimer's disease and Parkinson's disease, N Engl J Med, 348, 1356, 10.1056/NEJM2003ra020003 Morens, 1996, Epidemiologic observations on Parkinson's disease: incidence and mortality in a prospective study of middle-aged men, Neurology, 46, 1044, 10.1212/WNL.46.4.1044 Mayeux, 1995, The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988–1993, Am J Epidemiol, 142, 820, 10.1093/oxfordjournals.aje.a117721 de Rijk, 2000, Prevalence of Parkinson's disease in Europe: a collaborative study of population-based cohorts, Neurology, 54, S21 Li, 1985, A prevalence survey of Parkinson's disease and other movement disorders in the People's Republic of China, Arch Neurol, 42, 655, 10.1001/archneur.1985.04060070045013 Chen, 2001, Prevalence, incidence, and mortality of PD: a door-to-door survey in Ilan county, Taiwan, Neurology, 57, 1679, 10.1212/WNL.57.9.1679 Errea, 1999, Prevalence of Parkinson's disease in lower Aragon, Spain, Mov Disord, 14, 596, 10.1002/1531-8257(199907)14:4<596::AID-MDS1008>3.0.CO;2-U Fall, 1996, Age-standardized incidence and prevalence of Parkinson's disease in a Swedish community, J Clin Epidemiol, 49, 637, 10.1016/0895-4356(96)00003-0 Saunders-Pullman, 2003, Estrogens and Parkinson disease: neuroprotective, symptomatic, neither, or both?, Endocrine, 21, 81, 10.1385/ENDO:21:1:81 MacDonald, 2000, The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK, Brain, 123, 665, 10.1093/brain/123.4.665 Rajput, 1984, Epidemiology of parkinsonism: incidence, classification, and mortality, Ann Neurol, 16, 278, 10.1002/ana.410160303 Baldereschi, 2000, Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group, Neurology, 55, 1358, 10.1212/WNL.55.9.1358 Wang, 1991, Parkinson's disease in China. Coordinational Group of Neuroepidemiology, PLA, Chin Med J (Engl), 104, 960 Bower, 1999, Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976–1990, Neurology, 52, 1214, 10.1212/WNL.52.6.1214 Wang, 2002, The role of dopamine in motivation for food in humans: implications for obesity, Expert Opin Ther Targets, 6, 601, 10.1517/14728222.6.5.601 Langston, 1983, Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis, Science, 219, 979, 10.1126/science.6823561 Lai, 2002, Occupational and environmental risk factors for Parkinson's disease, Parkinsonism Relat Disord, 8, 297, 10.1016/S1353-8020(01)00054-2 Priyadarshi, 2000, A meta-analysis of Parkinson's disease and exposure to pesticides, Neurotoxicology, 21, 435 Baldi, 2003, Association between Parkinson's disease and exposure to pesticides in southwestern France, Neuroepidemiology, 22, 305, 10.1159/000071194 Firestone, 2005, Pesticides and risk of Parkinson disease: a population-based case-control study, Arch Neurol, 62, 91, 10.1001/archneur.62.1.91 Petrovitch, 2002, Plantation work and risk of Parkinson disease in a population-based longitudinal study, Arch Neurol, 59, 1787, 10.1001/archneur.59.11.1787 Betarbet, 2000, Chronic systemic pesticide exposure reproduces features of Parkinson's disease, Nat Neurosci, 3, 1301, 10.1038/81834 Jankovic, 2005, Searching for a relationship between manganese and welding and Parkinson's disease, Neurology, 64, 2021, 10.1212/01.WNL.0000166916.40902.63 Grandinetti, 1994, Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease, Am J Epidemiol, 139, 1129, 10.1093/oxfordjournals.aje.a116960 Paganini-Hill, 2001, Risk factors for parkinson's disease: the leisure world cohort study, Neuroepidemiology, 20, 118, 10.1159/000054770 Hernan, 2001, Cigarette smoking and the incidence of Parkinson's disease in two prospective studies, Ann Neurol, 50, 780, 10.1002/ana.10028 Hernan, 2002, A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease, Ann Neurol, 52, 276, 10.1002/ana.10277 Quik, 2004, Smoking, nicotine and Parkinson's disease, Trends Neurosci, 27, 561, 10.1016/j.tins.2004.06.008 Ross, 2000, Association of coffee and caffeine intake with the risk of Parkinson disease, JAMA, 283, 2674, 10.1001/jama.283.20.2674 Ascherio, 2001, Prospective study of caffeine consumption and risk of Parkinson's disease in men and women, Ann Neurol, 50, 56, 10.1002/ana.1052 Fink, 2001, Caffeine intake and the risk of incident Parkinson's disease: the Framingham Study, Mov Disord, 16, 984 Ascherio, 2004, Coffee consumption, gender, and Parkinson's disease mortality in the cancer prevention study II cohort: the modifying effects of estrogen, Am J Epidemiol, 160, 977, 10.1093/aje/kwh312 Xu, 2006, Estrogen prevents neuroprotection by caffeine in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease, J Neurosci, 26, 535, 10.1523/JNEUROSCI.3008-05.2006 Hernan, 2003, Alcohol consumption and the incidence of Parkinson's disease, Ann Neurol, 54, 170, 10.1002/ana.10611 Fall, 1999, Nutritional and occupational factors influencing the risk of Parkinson's disease: a case-control study in southeastern Sweden, Mov Disord, 14, 28, 10.1002/1531-8257(199901)14:1<28::AID-MDS1007>3.0.CO;2-O Jimenez-Jimenez, 1992, Premorbid smoking, alcohol consumption, and coffee drinking habits in Parkinson's disease: a case-control study, Mov Disord, 7, 339, 10.1002/mds.870070407 Benedetti, 2000, Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study, Neurology, 55, 1350, 10.1212/WNL.55.9.1350 Checkoway, 2002, Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake, Am J Epidemiol, 155, 732, 10.1093/aje/155.8.732 Zhang, 2002, Intakes of vitamins E and C, carotenoids, vitamin supplements, and PD risk, Neurology, 59, 1161, 10.1212/01.WNL.0000028688.75881.12 Morens, 1996, Case-control study of idiopathic Parkinson's disease and dietary vitamin E intake, Neurology, 46, 1270, 10.1212/WNL.46.5.1270 Chen, 2003, Dietary intakes of fat and risk of Parkinson's disease, Am J Epidemiol, 157, 1007, 10.1093/aje/kwg073 Abbott, 2003, Environmental, life-style, and physical precursors of clinical Parkinson's disease: recent findings from the Honolulu-Asia Aging Study, J Neurol, 250, III30 de Lau, 2005, Dietary fatty acids and the risk of Parkinson disease: the Rotterdam study, Neurology, 64, 2040, 10.1212/01.WNL.0000166038.67153.9F Chen, 2002, Diet and Parkinson's disease: a potential role of dairy products in men, Ann Neurol, 52, 793, 10.1002/ana.10381 Park, 2005, Consumption of milk and calcium in midlife and the future risk of Parkinson disease, Neurology, 64, 1047, 10.1212/01.WNL.0000154532.98495.BF Stocchi, 2003, Neuroprotection in Parkinson's disease: clinical trials, Ann Neurol, 53, S87, 10.1002/ana.10488 de Rijk, 1997, Dietary antioxidants and Parkinson disease: The Rotterdam Study, Arch Neurol, 54, 762, 10.1001/archneur.1997.00550180070015 Golbe, 1990, Follow-up study of early-life protective and risk factors in Parkinson's disease, Mov Disord, 5, 66, 10.1002/mds.870050116 Logroscino, 1996, Dietary lipids and antioxidants in Parkinson's disease: a population-based, case-control study, Ann Neurol, 39, 89, 10.1002/ana.410390113 Johnson, 1999, Adult nutrient intake as a risk factor for Parkinson's disease, Int J Epidemiol, 28, 1102, 10.1093/ije/28.6.1102 Scheider, 1997, Dietary antioxidants and other dietary factors in the etiology of Parkinson's disease, Mov Disord, 12, 190, 10.1002/mds.870120209 Farooqui, 1998, Lipid peroxides in the free radical pathophysiology of brain diseases, Cell Mol Neurobiol, 18, 599, 10.1023/A:1020261600498 Anderson, 1999, Dietary factors in Parkinson's disease: the role of food groups and specific foods, Mov Disord, 14, 21, 10.1002/1531-8257(199901)14:1<21::AID-MDS1006>3.0.CO;2-Y Hellenbrand, 1996, Diet and Parkinson's disease. II: a possible role for the past intake of specific nutrients—results from a self-administered food-frequency questionnaire in a case-control study, Neurology, 47, 644, 10.1212/WNL.47.3.644 Youdim, 2000, Essential fatty acids and the brain: possible health implications, Int J Dev Neurosci, 18, 383, 10.1016/S0736-5748(00)00013-7 Powers, 2003, Parkinson's disease risks associated with dietary iron, manganese, and other nutrient intakes, Neurology, 60, 1761, 10.1212/01.WNL.0000068021.13945.7F Chen, 2004, Folate intake and risk of Parkinson's disease, Am J Epidemiol, 160, 368, 10.1093/aje/kwh213 De Lau LM, Koudstaal PJ, Witteman J, Hofman A, Breteler MM. Dietary folate, vitamin B12, and vitamin B6 and the risk of Parkinson disease. Neurology (in press). McGeer, 2004, Inflammation and neurodegeneration in Parkinson's disease, Parkinsonism Relat Disord, 10, S3, 10.1016/j.parkreldis.2004.01.005 Chen, 2003, Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease, Arch Neurol, 60, 1059, 10.1001/archneur.60.8.1059 Chen, 2005, Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease, Ann Neurol, 58, 963, 10.1002/ana.20682 Tsang, 2000, Estrogen improves motor disability in parkinsonian postmenopausal women with motor fluctuations, Neurology, 54, 2292, 10.1212/WNL.54.12.2292 Currie, 2004, Postmenopausal estrogen use affects risk for Parkinson disease, Arch Neurol, 61, 886, 10.1001/archneur.61.6.886 Benedetti, 2001, Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study, Mov Disord, 16, 830, 10.1002/mds.1170 Marder, 1998, Postmenopausal estrogen use and Parkinson's disease with and without dementia, Neurology, 50, 1141, 10.1212/WNL.50.4.1141 Ragonese, 2004, Risk of Parkinson disease in women: effect of reproductive characteristics, Neurology, 62, 2010, 10.1212/WNL.62.11.2010 Gorell, 1994, Parkinson's disease and its comorbid disorders: an analysis of Michigan mortality data, 1970 to 1990, Neurology, 44, 1865, 10.1212/WNL.44.10.1865 Vanacore, 1999, Mortality cancer risk in parkinsonian patients: a population-based study, Neurology, 52, 395, 10.1212/WNL.52.2.395 D'Amelio, 2004, Tumor diagnosis preceding Parkinson's disease: a case-control study, Mov Disord, 19, 807, 10.1002/mds.20123 West, 2005, To die or grow: Parkinson's disease and cancer, Trends Neurosci, 28, 348, 10.1016/j.tins.2005.05.002 Elbaz, 2005, Risk of cancer after the diagnosis of Parkinson's disease: a historical cohort study, Mov Disord, 20, 719, 10.1002/mds.20401 Chen, 2005, Physical activity and the risk of Parkinson disease, Neurology, 64, 664, 10.1212/01.WNL.0000151960.28687.93 Wolters, 2000, Preclinical (premotor) Parkinson's disease, J Neurol, 247, II103, 10.1007/PL00022910 Hardy, 2003, Genes and parkinsonism, Lancet Neurol, 2, 221, 10.1016/S1474-4422(03)00350-8 Tanner, 1999, Parkinson disease in twins: an etiologic study, JAMA, 281, 341, 10.1001/jama.281.4.341 Healy, 2004, PINK, PANK, or PARK? A clinicians' guide to familial parkinsonism, Lancet Neurol, 3, 652, 10.1016/S1474-4422(04)00905-6 Valente, 2004, Hereditary early-onset Parkinson's disease caused by mutations in PINK1, Science, 304, 1158, 10.1126/science.1096284 Gilks, 2005, A common LRRK2 mutation in idiopathic Parkinson's disease, Lancet, 365, 415 Le, 2003, Mutations in NR4A2 associated with familial Parkinson disease, Nat Genet, 33, 85, 10.1038/ng1066 Tan, 2004, Analysis of MDR1 haplotypes in Parkinson's disease in a white population, Neurosci Lett, 372, 240, 10.1016/j.neulet.2004.09.046 Tan, 2000, Variability and validity of polymorphism association studies in Parkinson's disease, Neurology, 55, 533, 10.1212/WNL.55.4.533 Huang, 2004, APOE-epsilon2 allele associated with higher prevalence of sporadic Parkinson disease, Neurology, 62, 2198, 10.1212/01.WNL.0000130159.28215.6A Healy, 2004, Tau gene and Parkinson's disease: a case-control study and meta-analysis, J Neurol Neurosurg Psychiatry, 75, 962, 10.1136/jnnp.2003.026203 Maraganore, 2002, Case-control study of estrogen receptor gene polymorphisms in Parkinson's disease, Mov Disord, 17, 509, 10.1002/mds.1253 de Lau, 2005, Methylenetetrahydrofolate reductase C677T genotype and PD, Ann Neurol, 57, 927, 10.1002/ana.20509 van der Walt, 2003, Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease, Am J Hum Genet, 72, 804, 10.1086/373937 Elbaz, 2003, Survival study of Parkinson disease in Olmsted County, Minnesota, Arch Neurol, 60, 91, 10.1001/archneur.60.1.91 Hely, 1999, The Sydney multicentre study of Parkinson's disease: progression and mortality at 10 years, J Neurol Neurosurg Psychiatry, 67, 300, 10.1136/jnnp.67.3.300 Louis, 1997, Mortality from Parkinson disease, Arch Neurol, 54, 260, 10.1001/archneur.1997.00550150024011 Berger, 2000, Prognosis with Parkinson's disease in Europe: a collaborative study of population-based cohorts, Neurology, 54, S24 Morgante, 2000, Parkinson disease survival: a population-based study, Arch Neurol, 57, 507, 10.1001/archneur.57.4.507 Guttman, 2001, Parkinsonism in Ontario: increased mortality compared with controls in a large cohort study, Neurology, 57, 2278, 10.1212/WNL.57.12.2278 Fall, 2003, Survival time, mortality, and cause of death in elderly patients with Parkinson's disease: a 9-year follow-up, Mov Disord, 18, 1312, 10.1002/mds.10537 Herlofson, 2004, Mortality and Parkinson disease: A community based study, Neurology, 62, 937, 10.1212/01.WNL.0000115116.56955.50 Hughes, 2004, Mortality in Parkinson's disease and its association with dementia and depression, Acta Neurol Scand, 110, 118, 10.1111/j.1600-0404.2004.00292.x de Lau, 2005, Prognosis of Parkinson disease: risk of dementia and mortality: The Rotterdam Study, Arch Neurol, 62, 1265, 10.1001/archneur.62.8.1265 Emre, 2003, Dementia associated with Parkinson's disease, Lancet Neurol, 2, 229, 10.1016/S1474-4422(03)00351-X Hobson, 2004, Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom, Mov Disord, 19, 1043, 10.1002/mds.20216 Aarsland, 2003, Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study, Arch Neurol, 60, 387, 10.1001/archneur.60.3.387 Marder, 1995, The frequency and associated risk factors for dementia in patients with Parkinson's disease, Arch Neurol, 52, 695, 10.1001/archneur.1995.00540310069018 Levy, 2002, The association of incident dementia with mortality in PD, Neurology, 59, 1708, 10.1212/01.WNL.0000036610.36834.E0